Medivolve Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	4.6yrs

Recente managementupdates

Recent updates

CEO

Medivolve heeft geen CEO, of we hebben geen gegevens over hen.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Michael McCarthy	Member of Advisory Board	4.6yrs	geen gegevens	geen gegevens
James Beeland Rogers	Member of Strategic Advisory Board	4.6yrs	geen gegevens	geen gegevens
Joseph Sugerman	Member of Advisory Board	4.5yrs	geen gegevens	geen gegevens
Glenn Copeland	Member of Advisory Board	no data	geen gegevens	geen gegevens
Richard Dolan	Member of Strategic Advisory Board	4.6yrs	geen gegevens	geen gegevens
Paulo Iglessias	Member of Advisory Board	4.6yrs	geen gegevens	geen gegevens
Mike Mancias	Member of Advisory Board	4.6yrs	geen gegevens	geen gegevens

4.6yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MEDV.F wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).

Medivolve Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer

Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer

Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director

Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors

Medivolve Inc. Announces Chief Financial Officer Changes

Beverly Richardson Joins Questcap’s Board of Directors

Recent updates

Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer

Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer

Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director

Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors

Medivolve Inc. announced that it expects to receive CAD 4 million in funding

Medivolve Inc. announced that it has received CAD 1.2 million in funding

Medivolve Inc. Announces Chief Financial Officer Changes

Medivolve Inc. announced that it expects to receive CAD 2.6 million in funding

Medivolve Announces New COVID-19 Testing Mobile Vans Expanding On-Site Testing Opportunities to Schools, Workplaces, and Events

Medivolve Inc. announced that it has received CAD 12 million in funding

Medivolve Inc. (OTCPK:COPR.F) completed the acquisition of Electronic Health Platform of Myosin Inc.

Medivolve Inc. (OTCPK:COPR.F) signed a binding agreement to acquire Marbella Pharmacy for $0.5 million.

Medivolve Inc. and Marvel Diagnostics Inc. Complete First Stage Clinical Testing of BlowFISH

Medivolve Inc. Launches Business to Business Sales Initiatives

Medivolve Inc. (OTCPK:COPR.F) has signed a letter of intent to acquire Modern Rx LLC for $0.35 million.

Medivolve Inc. Announces the Launch of an Operating Model with Besser Brands in the State of Florida

Medivolve Inc. (NEOE:MEDV) signed a binding letter of intent to acquire Karland Health, LLC.

Medivolve Inc Collection Sites Provides Update with January Sales of 73,973 Tests At an Average Price of $96 Per Test

Medivolve Inc. (NEOE:MEDV) entered into an agreement to acquire Noble Bioscience Corp.

Medivolve Inc. (NEOE:MEDV) entered into a share purchase agreement to acquire a 13.2% stake in Marvel Diagnostics Inc. for $0.33 million.

Medivolve Inc. announced that it has received CAD 5 million in funding

Beverly Richardson Joins Questcap’s Board of Directors

QuestCap Provides COVID-19 Testing Kits to Kinross Gold’s Russian Operations

QuestCap Inc. announced that it expects to receive CAD 5 million in funding

QuestCap Inc. Sign Fifteen Lease Agreements Between Collection Sites, Llc and Orange County, and H&S Energy, Llc to Begin the Roll Out Network of Pop-Up Covid-19 Testing Sites

QuestCap Inc. (CNSX:QSC) completed the acquisition of Collection Sites, LLC.

QuestCap Inc. (CNSX:QSC) entered into a binding letter of intent to acquire Collection Sites, LLC for CAD 2.8 million.

QuestCap Inc. (CNSX:QSC) entered into arm's length agreement to acquire 40% stake in Spectral Analytics, Inc. for $2 million.

QuestCap Inc. (CNSX:QSC) acquired 40% issued and outstanding shares in Amino Therapeutics, Inc.

QuestCap Inc. (CNSX:QSC) completed the acquisition of 49% stake in Athletics and Health Solutions Inc.

QuestCap Inc. (CNSX:QSC) entered into a binding letter of agreement to acquire 28% stake in Sanaty IPS S.A.S. from Latin-Canada Pharma Inc. for CAD 2.7 million.

CEO

Bestuursleden

Gemiddelde duur